Tiny alpaca-derived antibodies point to targets preventing viral infection

Using tiny, alpaca-derived, single-domain antibody fragments, scientists have developed a method to perturb cellular processes in mammalian cells, allowing them to tease apart the roles that individual proteins play in these pathways. With improved knowledge of protein activity, scientists can better understand not only basic biology but also how disease corrupts cellular function and identify potential therapeutics to rectify these aberrations.